{"prompt": "['92', 'MC1488 WEE1', 'MCCC', 'Myeloproliferative Neoplasm Symptom Assessment Form', 'Total Symptom Score (MPN-SAF TSS)', 'Symptom', '1 to 10 (0 if absent) ranking', '1 is most favorable and 10 least favorable', 'Please rate your fatigue (weariness,', 'tiredness) by circling the one number that', 'best describes your WORST level of', '(No Fatigue) 0 1 2 3 4 5 6 7 8 9 10 (Worst Imaginable)', 'fatigue during past 24 hours', 'Circle the one number that describes, during the past week how much', 'difficulty you have had with each of the following symptoms', 'Filling up quickly when you eat (Early', '(Absent) 012345678910 (Worst Imaginable)', 'satiety)', 'Abdominal discomfort', '(Absent)0123456789 10 (Worst Imaginable)', 'Inactivity', '(Absent) 0 12345678910 (Worst Imaginable)', 'Problems with concentration - Compared', '(Absent) 0 1234567891 10 (Worst Imaginable)', 'to prior to my MPD', 'Numbness/Tingling (in my hands and feet)', '(Absent) 0 12345678910 (Worst Imaginable)', 'Night sweats', '(Absent) 0 12345678910 (Worst Imaginable)', 'Itching (pruritus)', '(Absent) 0 1 123456789 10 (Worst Imaginable)', 'Bone pain (diffuse not joint pain or', '(Absent) 0 1 234567891 10 (Worst Imaginable)', 'arthritis)', 'Fever (>100 F)', '(Absent) 0 1 2345678910 (Daily)', 'Unintentional weight loss last 6 months', '(Absent) 0 1234567891 10 (Worst Imaginable)', 'Thank you for taking the time to help us.']['93', 'MC1488 WEE1', 'MCCC', 'Appendix IX: Childbearing Potential & Contraception', 'Female patients are considered to be of childbearing potential unless', 'they are post-menopausal (defined as older than 50 years and amenorrhoeic', 'for at least 12 months following cessation of all exogenous hormonal', 'treatments),', 'there is documentation of irreversible surgical sterilisation by hysterectomy,', 'bilateral oophorectomy or bilateral salpingectomy (but not tubal ligation), or', 'they are 50 years or younger but have been amenorrhoeic for at least 12', 'months following the cessation of exogenous hormonal treatments, and have', 'serum follicle-stimulating hormone (FSH) and luteinising hormone (LH)', 'levels in the postmenopausal range for the institution.', 'Female patients who are of childbearing potential must agree to use adequate', 'contraceptive measures (as defined below) for the duration of study participation,', 'and for 6 months after the final dose of study drug; cessation of birth control after', 'this point should be discussed with a responsible physician. They also may not', 'be breast feeding and must have a negative serum or urine pregnancy test within', '72 hours prior to start of study treatment.', 'Acceptable methods of contraception include true abstinence in line with the', 'preferred and usual lifestyle ch', 'mised', 'partner, and methods listed in', 'All methods of contraception (with the exception of total abstinence) should be', 'used in combination with the use of a condom by their male sexual partner for', 'intercourse. Periodic abstinence, the rhythm method, and the withdrawal method', 'are not acceptable methods of birth control.', 'Should a woman become pregnant or suspect she is pregnant while participating', 'in this study, she should inform her treating physician immediately.', 'Effective Methods of Contraception', 'Barrier Methods', 'Intrauterine Device Methods', 'Hormonal Methods', 'Cap plus spermicide', 'Copper T', 'Any registered and marketed', 'Sponge plus spermicide', 'Levonorgestrel-releasing', 'contraceptive agent that contains', 'Diaphragm plus spermicide', 'intrauterine system (eg,', 'an estrogen and/or a', 'MirenaR)', 'progestational agent (including', 'oral, subcutaneous, intrauterine,', 'or intramuscular agents) such as', 'Implants', 'Hormone shot or injection', 'Combined pill', 'Minipill', 'Patch', 'a', 'This is also considered a hormonal method.']\n\n###\n\n", "completion": "END"}